Ebola vaccines from GSK, Merck elicit yearlong response, study finds - FiercePharma

FiercePharma
Ebola vaccines from GSK, Merck elicit yearlong response, study finds
FiercePharma
After initially setting out to test two vaccines on 28,000 volunteers during West Africa's deadly Ebola epidemic, a U.S.-Liberia research team had to dramatically reduce its aspirations when the outbreak started coming to an end. But the investigators ...
Two experimental Ebola vaccines show year-long promiseJamaica Observer
Promising results in large trial of two Ebola vaccine candidatesThe Pharma Le